Ivermectin In Treatment of COVID 19 Patients

Summary

as Egypt suffered a lot during the pandemic of COVID 19 with limited drug choices, many of the patients could not acheive viral clearence with the standard module of care teh idea of introduction of new medications in the treatment protocol of COVID 19 managment. Ivermectin had shown a promising results in vitro studies and in limited in vivo studies. this clinical trial may open a new hope for COVID 19 patients as a new and cheap line of treatment

Timeline

Start

2020-06-09

Primary completion

2020-07-01

Completion

2020-09-01

Drugs

Indications